发明名称 |
MODIFIED-RELEASE DOSAGE FORMS OF 5-HT2C AGONISTS USEFUL FOR WEIGHT MANAGEMENT |
摘要 |
The present invention relates to methods for weight management that utilize modified-release dosage forms comprising (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine salts and crystalline forms thereof. The present invention further relates to (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine salts, crystalline forms thereof and modified-release dosage forms comprising them. |
申请公布号 |
CA2808912(A1) |
申请公布日期 |
2012.03.08 |
申请号 |
CA20112808912 |
申请日期 |
2011.08.31 |
申请人 |
ARENA PHARMACEUTICALS, INC. |
发明人 |
SHAO, ZEZHI JESSE;BLACKBURN, ANTHONY C.;GROTTICK, ANDREW J.;MORGAN, MICHAEL;RUETER, JAIMIE KARYN;SHIFRINA, ANNA;STIRN, SCOTT;YANG, LIBO;YOON, WOO HYUN |
分类号 |
A61K9/20;A23L1/00;A61K9/28;A61K31/00;A61K31/55;C07D401/00 |
主分类号 |
A61K9/20 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|